PharmaEssentia Japan K.K.
4 clinical trials · Sponsor
◉ Watch PharmaEssentia Japan K.K.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate P1101 in Japanese PV Patients (NCT06002490) | PharmaEssentia Japan K.K. | 2023-10-17 |
| Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients (NCT04655092) | PharmaEssentia Japan K.K. | 2021-01-19 |
| Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply (NCT04182100) | PharmaEssentia Japan K.K. | 2019-12-20 |
| Safety, Tolerability, Pharmacokinetics & Pharmacodynamics Study of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects (NCT03546465) | PharmaEssentia Japan K.K. | 2018-05-07 |
Track PharmaEssentia Japan K.K. automatically
Every clearance here is in the API, with alerts when new ones post.